NO20016047D0 - Hyaluronidase fra Hirudinaria manillensis, isolering, rensing og rekombinant fremgangsmåte for fremstilling derav - Google Patents

Hyaluronidase fra Hirudinaria manillensis, isolering, rensing og rekombinant fremgangsmåte for fremstilling derav

Info

Publication number
NO20016047D0
NO20016047D0 NO20016047A NO20016047A NO20016047D0 NO 20016047 D0 NO20016047 D0 NO 20016047D0 NO 20016047 A NO20016047 A NO 20016047A NO 20016047 A NO20016047 A NO 20016047A NO 20016047 D0 NO20016047 D0 NO 20016047D0
Authority
NO
Norway
Prior art keywords
hyaluronidase
isolation
purification
preparation
hirudinaria manillensis
Prior art date
Application number
NO20016047A
Other languages
English (en)
Other versions
NO20016047L (no
Inventor
Maria Kordowicz
Detlef Guessow
Uwe Hofmann
Tedeausz Pacuszka
Andrzej Gardas
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20016047D0 publication Critical patent/NO20016047D0/no
Publication of NO20016047L publication Critical patent/NO20016047L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
NO20016047A 1999-06-12 2001-12-11 Hyaluronidase fra Hirudinaria manillensis, isolering, rensing og rekombinant fremgangsmåte for fremstilling derav NO20016047L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99111468 1999-06-12
PCT/EP2000/005181 WO2000077221A1 (en) 1999-06-12 2000-06-06 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production

Publications (2)

Publication Number Publication Date
NO20016047D0 true NO20016047D0 (no) 2001-12-11
NO20016047L NO20016047L (no) 2001-12-11

Family

ID=8238352

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016047A NO20016047L (no) 1999-06-12 2001-12-11 Hyaluronidase fra Hirudinaria manillensis, isolering, rensing og rekombinant fremgangsmåte for fremstilling derav

Country Status (23)

Country Link
US (1) US7049124B1 (no)
EP (1) EP1185666B1 (no)
JP (1) JP2003502045A (no)
KR (1) KR20020011138A (no)
CN (1) CN1355850A (no)
AR (1) AR024335A1 (no)
AT (1) ATE324452T1 (no)
AU (1) AU6149300A (no)
BR (1) BR0011500A (no)
CA (1) CA2376467A1 (no)
CZ (1) CZ20014383A3 (no)
DE (1) DE60027562T2 (no)
DK (1) DK1185666T3 (no)
ES (1) ES2258976T3 (no)
HK (1) HK1046297A1 (no)
HU (1) HUP0201452A2 (no)
MX (1) MXPA01012806A (no)
NO (1) NO20016047L (no)
PL (1) PL352060A1 (no)
PT (1) PT1185666E (no)
SK (1) SK17612001A3 (no)
WO (1) WO2000077221A1 (no)
ZA (1) ZA200200233B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610292B2 (en) 1995-11-22 2003-08-26 Ista Pharmaceuticals, Inc. Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
US5866120A (en) 1995-11-22 1999-02-02 Advanced Corneal Systems, Inc. Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
BR9908692A (pt) 1998-03-09 2001-12-04 Ista Pharmaceuticals Inc Uso de agentes de enrijecimento corneal emortocerotologia enzimática
CA2522544A1 (en) * 2003-04-15 2004-10-28 Ista Pharmaceuticals, Inc. Process for isolating and purifing ovine hyaluronidase
WO2004110479A1 (de) * 2003-05-27 2004-12-23 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Hyaluronatlyase enthaltendes mittel zur behandlung des akuten myokardinfarktes bzw. symptomen darauf sowie zur behandlung von postinfarktioneller myokarditis und myokardischämie
WO2005030962A1 (en) * 2003-09-26 2005-04-07 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Synthetic heparanase molecules and uses thereof
US8288142B2 (en) * 2007-06-19 2012-10-16 Uvarkina Tamara P Hyaluronidase and method of use thereof
GB0717166D0 (en) * 2007-09-04 2007-10-17 Univ Brighton Method for stabilisation of purified P-Glycoprotein
EP3760715B1 (en) * 2008-03-06 2021-08-04 Halozyme, Inc. Large-scale production of soluble hyaluronidase
EP2177227B1 (en) * 2008-10-14 2013-03-20 Burgard, Gunter, Dr. med. Use of hyaluronidase for the prevention or treatment of arterial hypertension.
AU2012318303B2 (en) 2011-10-18 2015-09-03 Csl Behring Gmbh Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of Factor VIII
EP2698636A1 (en) * 2012-08-13 2014-02-19 Fundació Institut d'Investigació Biomèdica de Bellvitge Methods and reagents for prevention and/or treatment of transplant rejection
US8790711B2 (en) 2012-09-17 2014-07-29 Biopep Solutions, Inc. Treating diabetes with a whole, leech saliva extract
KR101454646B1 (ko) 2012-11-05 2014-10-27 (주)한국비엠아이 히알루로니다아제의 안정화 제제 및 이를 포함하는 액상제제
CN103060291B (zh) * 2012-12-28 2014-10-08 青岛九龙生物医药有限公司 一种玻璃酸酶的提取方法
CN103695448B (zh) * 2013-07-29 2016-08-17 江南大学 一种透明质酸酶编码基因及其发酵生产和纯化方法
US9279111B2 (en) * 2013-07-29 2016-03-08 Jiangnan University Leech hyaluronidase and its application
CN104263666B (zh) * 2014-09-12 2017-07-14 江南大学 一种产小分子透明质酸的重组毕赤酵母及其构建方法
CN106148302A (zh) * 2016-07-08 2016-11-23 中国人民解放军军事医学科学院生物工程研究所 一种重组蛋白质的纯化方法
CN106520728B (zh) * 2016-11-08 2019-06-21 江南大学 一种提高水蛭透明质酸酶酶活的方法
CN109298113B (zh) * 2018-12-11 2021-06-18 华熙生物科技股份有限公司 一种测定包含有柠檬酸的溶液中的透明质酸含量的方法
JP2023522966A (ja) * 2020-04-20 2023-06-01 ファーマクト ホールディング アーゲー 修飾細菌性ヒアルロニダーゼポリペプチド、製造方法、医薬組成物およびそれらの使用
CN112915106A (zh) * 2021-02-05 2021-06-08 张虎山 一种肿瘤免疫微环境调控剂的制备及其应用
WO2023067008A1 (en) * 2021-10-19 2023-04-27 Pharmact Holding Ag A production of a purified modified bacterial hyaluronidase polypeptide, pharmaceutical compositions and their uses
CN116640745B (zh) * 2023-06-29 2023-12-08 江南大学 透明质酸酶突变体及其在水解硫酸软骨素中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8504025D0 (en) 1985-02-16 1985-03-20 Biopharm Ltd Hyaluronidase
DE4440892A1 (de) * 1994-11-17 1996-05-23 Gruenenthal Gmbh Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
US5747027A (en) 1995-04-07 1998-05-05 The Regents Of The University Of California BH55 hyaluronidase

Also Published As

Publication number Publication date
KR20020011138A (ko) 2002-02-07
SK17612001A3 (sk) 2002-04-04
EP1185666A1 (en) 2002-03-13
ES2258976T3 (es) 2006-09-16
JP2003502045A (ja) 2003-01-21
DE60027562T2 (de) 2006-11-02
WO2000077221A1 (en) 2000-12-21
PL352060A1 (en) 2003-07-28
CZ20014383A3 (cs) 2002-03-13
NO20016047L (no) 2001-12-11
HUP0201452A2 (en) 2002-08-28
DE60027562D1 (de) 2006-06-01
CN1355850A (zh) 2002-06-26
BR0011500A (pt) 2002-03-12
ATE324452T1 (de) 2006-05-15
PT1185666E (pt) 2006-09-29
US7049124B1 (en) 2006-05-23
AR024335A1 (es) 2002-10-02
MXPA01012806A (es) 2002-09-02
DK1185666T3 (da) 2006-07-03
CA2376467A1 (en) 2000-12-21
AU6149300A (en) 2001-01-02
HK1046297A1 (zh) 2003-01-03
ZA200200233B (en) 2003-06-25
EP1185666B1 (en) 2006-04-26

Similar Documents

Publication Publication Date Title
NO20016047D0 (no) Hyaluronidase fra Hirudinaria manillensis, isolering, rensing og rekombinant fremgangsmåte for fremstilling derav
NL300939I2 (nl) Benralizumab
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO994392D0 (no) Oksiranderivat og fremgangsmÕte for dets fremstilling
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
DE60034558D1 (de) Alpha-amylase-varianten
ID25682A (id) Metode untuk melelehkan kaca
NO995660D0 (no) Fremgangsmåte ved kommunikasjon og anordning for samme
EE200000623A (et) Puhverseadis
DK1261697T3 (da) Kuldeaktiv beta-galactosidase, fremgangsmåde til fremstilling heraf og anvendelsen deraf
NO20015399L (no) System og fremgangsmåte for produktdemontering
NO20022834L (no) Zeolitt SSZ-50, fremgangsmåte for fremstilling og anvendelse av denne
NO20052188D0 (no) System og fremgangsmate for fremstilling av polysulfid
NO20040368L (no) Fremgangsmate til fremstilling og rensing av natriumhydrid
NO20013735L (no) Fremgangsmåte til fremstilling av di-iso-butaner, di-iso- butener og di-n-butener fra feltbutaner
NO20021569D0 (no) Rensete kitiner og fremgangsmåte for deres fremstilling
NO20022119D0 (no) Fremgangsmåte for å lage en sikt, en sikt og et system for å lage en sikt
DE50009931D1 (de) Gaserzeugungssystem
GB2389182B (en) Method of purifying b-secretase
DE60034671D1 (de) Implantatsystem
NO308484B1 (no) FremgangsmÕte og system for utvinning av energi fra brønnstrøm
DK1046719T3 (da) D-galactosesammensætning og fremgangsmåde til fremstilling deraf
NO991111D0 (no) Nytt ensileringsmiddel, fremgangsmÕte for fremstilling av dette ensileringsmiddelet og bruk av dette
NO20020404D0 (no) Streptograminderivater, deres produksjon og forbindelser derav
GB9909749D0 (en) Purification method

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application